Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Enveric Biosciences Stock News

ENVBNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$1.17

-0.06-4.88%

At close: -

$1.21

0.043.42%

After Hours: 9:22 AM EDT

Enveric Biosciences (ENVB) Forecast

News

Earnings Enveric Biosciences (ENVB) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Enveric Biosciences Stock News | NASDAQ:ENVB | Benzinga

Get the latest news on Enveric Biosciences stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Enveric Biosciences performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, March 31, 2025

Enveric Biosciences Q4 2024 GAAP EPS $(4.83) ...
Benzinga Newsdesk - Mar 31, 2025, 8:18AM

Thursday, March 27, 2025

CORRECTION: Enveric Biosciences Canada Inc. F...
Benzinga Newsdesk - Mar 27, 2025, 2:00PM

Thursday, March 06, 2025

HC Wainwright & Co. Reiterates Buy on Enveric...
Benzinga Newsdesk - Mar 6, 2025, 1:58PM
Enveric Biosciences Announces It Will Build O...
Benzinga Newsdesk - Mar 6, 2025, 10:02AM
Enveric Biosciences Says On Mar. 4 Regained N...
Benzinga Newsdesk - Mar 6, 2025, 9:33AM

Wednesday, February 26, 2025

Dow Dips Over 100 Points; TJX Earnings Top Views
Avi Kapoor - Feb 26, 2025, 2:57PM
Nasdaq Surges 150 Points; Lowe's Posts Upbeat Earnings
Avi Kapoor - Feb 26, 2025, 1:05PM
Market-Moving News for February 26th
Benzinga Newsdesk - Feb 26, 2025, 7:21AM
Enveric Biosciences shares are trading higher...
Benzinga Newsdesk - Feb 26, 2025, 6:10AM
US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert
Rishabh Mishra - Feb 26, 2025, 6:06AM
Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Feb 26, 2025, 5:16AM

Tuesday, February 25, 2025

Enveric Biosciences shares are trading higher...
Benzinga Newsdesk - Feb 25, 2025, 4:31PM
EXCLUSIVE: Non-Hallucinogenic Psychedelic Compounds Show Promise For Treating Addiction And ADHD
Javier Hasse - Feb 25, 2025, 4:06PM
Enveric Biosciences Announces Issuance Of U.S...
Benzinga Newsdesk - Feb 25, 2025, 1:32PM

Tuesday, February 04, 2025

Enveric Biosciences Inks Two Licensing Agreements With Restoration Biologics To Treat Joint Disease
Vandana Singh - Feb 4, 2025, 8:00AM

Friday, January 31, 2025

Dow Edges Lower; Exxon Mobil Earnings Top Views
Avi Kapoor - Jan 31, 2025, 12:19PM
Nasdaq Jumps Over 150 Points; Apple Posts Upbeat Earnings
Avi Kapoor - Jan 31, 2025, 9:46AM
Enveric Biosciences shares are trading lower ...
Benzinga Newsdesk - Jan 31, 2025, 8:31AM
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Jan 31, 2025, 5:11AM
Reported Earlier, Enveric Biosciences Prices ...
Benzinga Newsdesk - Jan 31, 2025, 2:00AM

Thursday, January 30, 2025

Enveric Biosciences shares are trading higher...
Benzinga Newsdesk - Jan 30, 2025, 4:16PM
Enveric Biosciences Receives Notice Of Allowa...
Benzinga Newsdesk - Jan 30, 2025, 4:08PM

Wednesday, January 29, 2025

Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk - Jan 28, 2025, 7:50PM

Saturday, January 25, 2025

Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk - Jan 24, 2025, 7:50PM

Tuesday, January 07, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jan 7, 2025, 4:06PM

Monday, December 02, 2024

Enveric Biosciences Announced That The United...
Benzinga Newsdesk - Dec 2, 2024, 8:07AM

Wednesday, November 27, 2024

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Nov 27, 2024, 4:05PM

Monday, November 25, 2024

Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results
Nina Zdinjak - Nov 25, 2024, 9:00AM

Tuesday, November 19, 2024

Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Nov 19, 2024, 6:30AM

Monday, November 18, 2024

Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders
Nina Zdinjak - Nov 18, 2024, 10:06AM

Thursday, November 14, 2024

Enveric Biosciences Q3 2024 GAAP EPS $(0.24) ...
Benzinga Newsdesk - Nov 14, 2024, 4:48PM

Tuesday, November 12, 2024

Enveric Biosciences Canada Granted U.S. Paten...
Benzinga Newsdesk - Nov 12, 2024, 4:22PM
Enveric Biosciences Enters $62M Out-Licensing...
Benzinga Newsdesk - Nov 12, 2024, 9:03AM
Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal
Franca Quarneti - Nov 12, 2024, 9:00AM

Monday, November 04, 2024

Enveric Biosciences Expands Patent Portfolio ...
Benzinga Newsdesk - Nov 4, 2024, 9:03AM
Enveric Biosciences Expands Mental Health Patent Portfolio With 5 New Additions
Franca Quarneti - Nov 4, 2024, 9:00AM

Wednesday, October 23, 2024

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Oct 23, 2024, 4:31PM

Tuesday, October 15, 2024

Enveric Biosciences Advances Testing Of Its Non-Hallucinogenic Psychedelic
Juan Spínelli - Oct 15, 2024, 11:27AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Oct 15, 2024, 8:08AM
Enveric Biosciences Announces Pharmacology an...
Benzinga Newsdesk - Oct 15, 2024, 8:06AM

Friday, October 04, 2024

Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
Juan Spínelli - Oct 4, 2024, 3:39PM

Thursday, September 26, 2024

Enveric Biosciences Presents Data Highlightin...
Benzinga Newsdesk - Sep 26, 2024, 8:42AM

Wednesday, September 25, 2024

Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
Jelena Martinovic - Sep 25, 2024, 8:30AM

Monday, September 23, 2024

'DEA Calls For Massive Increases In Psilocybi...
Benzinga Newsdesk - Sep 23, 2024, 1:41PM

Tuesday, August 20, 2024

Enveric Biosciences Granted US Patent #120654...
Benzinga Newsdesk - Aug 20, 2024, 3:54PM

Tuesday, August 13, 2024

Aries Science & Technology and Enveric Biosci...
Benzinga Newsdesk - Aug 13, 2024, 8:08AM

Monday, August 12, 2024

Enveric Biosciences Q2 2024 GAAP EPS $(0.23) ...
Benzinga Newsdesk - Aug 12, 2024, 5:39PM

Tuesday, July 30, 2024

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor - Jul 30, 2024, 1:53PM
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Jul 30, 2024, 5:50AM

Thursday, July 25, 2024

Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
Nina Zdinjak - Jul 25, 2024, 8:00AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved